Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Yoshihara

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Obstetrics and Gynaecology Research|May 14, 2026
Changes in Epithelial Ovarian Cancer Treatment and Advent of Maintenance Therapy From Real-World DataEmiri Miyamoto, Kazumasa Mogi, Masato Yoshihara, et al.
Scientific Reports|December 3, 2021
Clinical effects of cervical conization with positive margins in cervical cancerYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Placenta|March 7, 2022
Crosstalk between foetal vasoactive peptide hormones and placental aminopeptidases regulates placental blood flow: Its significance in preeclampsiaMasato Yoshihara, Shigehiko Mizutani, Kunio Matsumoto, et al.
Gynecologic Oncology|April 19, 2023
Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathwayXuboya Chang, Satoshi Tamauchi, Kosuke Yoshida, et al.
International Journal of Molecular Sciences|December 29, 2020
Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian CancerKazuhisa Kitami, Masato Yoshihara, Yoshihiro Koya, et al.
Scientific Reports|June 1, 2024
Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancerRyosuke Uekusa, Akira Yokoi, Eri Watanabe, et al.
Cancer Biomarkers : Section a of Disease Markers|June 11, 2023
The prognostic significance of DDIT4 in endometrial cancerNobuhisa Yoshikawa, Kosuke Yoshida, Wenting Liu, et al.
Cancers|April 3, 2021
Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal DisseminationKazumasa Mogi, Masato Yoshihara, Shohei Iyoshi, et al.
International Journal of Clinical Oncology|July 29, 2022
Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter studyMasato Yoshihara, Kazumasa Mogi, Kazuhisa Kitami, et al.
Japanese Journal of Clinical Oncology|May 26, 2023
The prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer: a multi-center study with a propensity score-adjusted analysisEmiri Miyamoto, Hironori Suzuki, Masato Yoshihara, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Obstetrics and Gynaecology Research|May 14, 2026
Changes in Epithelial Ovarian Cancer Treatment and Advent of Maintenance Therapy From Real-World DataEmiri Miyamoto, Kazumasa Mogi, Masato Yoshihara, et al.
Scientific Reports|December 3, 2021
Clinical effects of cervical conization with positive margins in cervical cancerYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Placenta|March 7, 2022
Crosstalk between foetal vasoactive peptide hormones and placental aminopeptidases regulates placental blood flow: Its significance in preeclampsiaMasato Yoshihara, Shigehiko Mizutani, Kunio Matsumoto, et al.
Gynecologic Oncology|April 19, 2023
Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathwayXuboya Chang, Satoshi Tamauchi, Kosuke Yoshida, et al.
International Journal of Molecular Sciences|December 29, 2020
Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian CancerKazuhisa Kitami, Masato Yoshihara, Yoshihiro Koya, et al.
Scientific Reports|June 1, 2024
Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancerRyosuke Uekusa, Akira Yokoi, Eri Watanabe, et al.
Cancer Biomarkers : Section a of Disease Markers|June 11, 2023
The prognostic significance of DDIT4 in endometrial cancerNobuhisa Yoshikawa, Kosuke Yoshida, Wenting Liu, et al.
Cancers|April 3, 2021
Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal DisseminationKazumasa Mogi, Masato Yoshihara, Shohei Iyoshi, et al.
International Journal of Clinical Oncology|July 29, 2022
Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter studyMasato Yoshihara, Kazumasa Mogi, Kazuhisa Kitami, et al.
Japanese Journal of Clinical Oncology|May 26, 2023
The prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer: a multi-center study with a propensity score-adjusted analysisEmiri Miyamoto, Hironori Suzuki, Masato Yoshihara, et al.
Pageof 13